Search Ontology:
ChEBI

beta-D-GalpNAc-(1->4)-beta-D-GlcpNAc-(1->3)-beta-D-Galp

Term ID
CHEBI:147455
Synonyms
  • 2-acetamido-2-deoxy-beta-D-galacto-hexopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-gluco-hexopyranosyl-(1->3)-beta-D-galacto-hexopyranose
  • 2-acetamido-2-deoxy-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-beta-D-galactopyranose
  • GalNAc(b1-4)GlcNAc(b1-3)b-Gal
  • N-[(2S,3R,4R,5R,6R)-2-[(2R,3S,4R,5R,6S)-5-acetamido-4-hydroxy-2-(hydroxymethyl)-6-[(2R,3R,4S,5S,6R)-2,3,5-trihydroxy-6-(hydroxymethyl)oxan-4-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
Definition
An amino trisaccharide consisting of 2-acetamido-2-deoxy-β-D-galactopyranose, 2-acetamido-2-deoxy-β-D-glucopyranose and β-D-galactopyranose residues joined in sequence by (1→4) and (1→3) glycosidic bonds.
References
  • glygen:G11049II
  • glytoucan:G11049II
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from beta-D-GalpNAc-(1->4)-beta-D-GlcpNAc-(1->3)-beta-D-Galp
Phenotype where environments contain beta-D-GalpNAc-(1->4)-beta-D-GlcpNAc-(1->3)-beta-D-Galp
Phenotype modified by environments containing beta-D-GalpNAc-(1->4)-beta-D-GlcpNAc-(1->3)-beta-D-Galp
Phenotype affecting beta-D-GalpNAc-(1->4)-beta-D-GlcpNAc-(1->3)-beta-D-Galp
Human Disease Model